Exabis Library
Welcome to the e-CCO Library!
OP032: Outcome of pregnancies in female IBD patients treated with vedolizumab
2018
ECCO'18 Vienna
Friday, 23 March 2018, 12:23 PM
1
OP034: Efficacy and safety of abrilumab in subjects with Moderate to Severe Ulcerative Colitis: Results of a phase 2b, randomised, double-blind, multiple-dose, placebo-controlled study
2017
ECCO'17 Barcelona
Wednesday, 15 March 2017, 2:04 PM by ECCO Administrator
1
OP034: The initiation of thiopurines in elderly patients with Inflammatory Bowel Disease is associated with an increased risk of adverse effects: A case-control study of the eneida registry
2018
ECCO'18 Vienna
Friday, 23 March 2018, 12:23 PM
1
OP035: NUDT15 variants contribute to thiopurine-induced myelosuppression in European populations
2018
ECCO'18 Vienna
Friday, 23 March 2018, 12:23 PM
1
OP035: Efficacy and safety of abrilumab (AMG 181/MEDI 7183) therapy for Moderate to Severe Crohn’s Disease
2017
ECCO'17 Barcelona
Wednesday, 15 March 2017, 2:03 PM by ECCO Administrator
1
OP036: Long-term risk of advanced neoplasia after colonic low-grade dysplasia in patients with Inflammatory Bowel Disease: A nationwide cohort study
2018
ECCO'18 Vienna
Friday, 23 March 2018, 12:23 PM
1
OP036: Short duration, low intensity pooled faecal microbiota transplantation induces remission in patients with mild- moderately active Ulcerative Colitis: A randomised controlled trial
2017
ECCO'17 Barcelona
Wednesday, 15 March 2017, 1:55 PM by ECCO Administrator
1
OP037: Infants born to mothers with Inflammatory Bowel Disease exhibit distinct microbiome features that persist up to 3 months of life
2017
ECCO'17 Barcelona
Wednesday, 15 March 2017, 1:56 PM by ECCO Administrator
1
OP037: Risk of cancer in Inflammatory Bowel Disease patients is associated with age and recent use of immunomodulators, while biologics and aminosalicylates are protective factors - a cross-sectional and follow-up analysis of the Swiss IBD cohort Study
2018
ECCO'18 Vienna
Friday, 23 March 2018, 12:23 PM
1
OP038: Impact of ileocecal resection in Crohn’s Disease patients on mucosal microbiota
2017
ECCO'17 Barcelona
Wednesday, 15 March 2017, 1:52 PM by ECCO Administrator
1
OP03: Reduced need for surgery and medical therapy after early ileocaecal resection for Crohn’s Disease: Long-term follow up of the LIR!C trial
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 4:58 PM
1
OP04: Long-term outcomes after ileocolonic resection in Crohn’s Disease according to severity of early endoscopic recurrence
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 4:58 PM
1
OP05: Validation of the Lémann Index in Crohn’s Disease
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 4:58 PM
1
OP07: Analysing intestinal organoids in a multi-omics, systems biology framework to investigate functional processes affected in Crohn’s disease due to autophagy impairment
2019
ECCO'19 Copenhagen
Tuesday, 28 May 2019, 3:32 PM
1
OP07: The epidemiology of Inflammatory Bowel Diseases among immigrants to Denmark: a population-based cohort study
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 4:58 PM
1
OP08: Inflammatory Bowel Disease and risk of small bowel cancer: A binational population-based cohort study from Denmark and Sweden
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 4:58 PM
1
OP09: Immunomodulatory mechanisms of faecal microbiota transplantation is associated with clinical response in Ulcerative Colitis – early results from STOP-Colitis
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 4:58 PM
1
OP10: IgA coating of intestinal microbiota is associated with Inflammatory Bowel Disease in twin pairs discordant for Inflammatory Bowel Disease
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 4:58 PM
1
OP10: Systems genomics of ulcerative colitis: combining GWAS and signalling networks for patient stratification and individualised drug targeting in ulcerative colitis
2019
ECCO'19 Copenhagen
Tuesday, 28 May 2019, 3:32 PM
1
OP11: Organoids derived from inflamed intestinal biopsies of patients with ulcerative colitis lose their inflammatory phenotype during ex vivo culture
2019
ECCO'19 Copenhagen
Tuesday, 28 May 2019, 3:32 PM
1